Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

23 jun 2013 8:30 a.m. - 27 jun 2013 12:45 p.m.

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Session Chair(s)

Celine  Adessi, PHD

Celine Adessi, PHD

Senior Clinical Safety Scientist

F. Hoffmann - La Roche, Switzerland

Learning Objective : Identify gaps in managing human risk of drugs inducing non-monitorable toxicology findings in animals; Evaluate alternative approaches in refining animal testing for human health risk assessment; Discuss the importance of nonclinical juvenile animal guidance in pediatric drug development.

Speaker(s)

Celine  Adessi, PHD

Drug-induced Vasculitis: A Non Monitorable Toxicology Finding and A Dilemma in Translational Medicine

Celine Adessi, PHD

F. Hoffmann - La Roche, Switzerland

Senior Clinical Safety Scientist

Andrea  Greiter-Wilke, DVM, PHD

Nonclinical Assessment of Blood Pressure Changes: Challenges, New Technologies and Translation to Human

Andrea Greiter-Wilke, DVM, PHD

F. Hoffmann-La Roche AG, Switzerland

Head, Safety Pharmacology

Dinah  Duarte, MSC

Juvenile Animal Studies and Pediatric Drug Development: Systematic or Case-by-case?

Dinah Duarte, MSC

European Medicines Agency, Netherlands

Signal Management Lead

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.